The last decade has seen the complexity, size, and costs of clinical trials increase, which has made the task of guaranteeing data quality progressively difficult.
Marc Buyse
Advertisement
Marc Buyse, ScD, is director, International Drug Development Institute (IDDI), Brussels, Belgium,+32 2 6468918, fax: +32 2 6468662, email: marc.buyse@iddi.com.
Articles by Marc Buyse
The final version of the EMA Reflection Paper on Risk Based Quality Management in Clinical Trials is now available.
Advertisement
Latest Updated Articles
Centralized Statistical Monitoring As a Way to Improve the Quality of Clinical DataPublished: March 24th 2014 | Updated:
EMA Reflection Paper on Risk Based Quality Management in Clinical TrialsPublished: December 11th 2013 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
MATTERHORN Trial Findings Signal Paradigm Shift in Early Gastric Cancer Care
2
Reducing Site Burden Through Better Technology Integration in Clinical Trials
3
ACT Brief: AstraZeneca Expands Immunotherapy Reach as Thermo Fisher’s $8.8B Deal Signals New Phase for Digital Trials
4
ACT Brief: AI, Equity, and Innovation Drive Clinical Research Forward
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
